Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (16)

2022

  1. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

2020

  1. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

  2. The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma

    Oncotarget, Vol. 11, Núm. 13, pp. 1172-1185

2010

  1. Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer

    Journal of Pathology, Vol. 222, Núm. 1, pp. 89-98

2009

  1. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

    Human Molecular Genetics, Vol. 18, Núm. 7, pp. 1343-1352

2008

  1. Erratum: Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer (Epigenetics vol. 3(2) (64-68))

    Epigenetics

  2. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

    Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356

  3. Frequent BRG1/SMARCA4-Inactivating mutations in human lung cancer cell lines

    Human Mutation, Vol. 29, Núm. 5, pp. 617-622

  4. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer

    Epigenetics, Vol. 3, Núm. 2, pp. 64-68

2007

  1. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer

    Oncogene, Vol. 26, Núm. 11, pp. 1616-1625

2006

  1. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy

    Journal of Clinical Oncology, Vol. 24, Núm. 26, pp. 4333-4339

2005

  1. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells

    Human Molecular Genetics, Vol. 14, Núm. 7, pp. 973-982

2004

  1. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations

    Oncogene, Vol. 23, Núm. 29, pp. 5084-5091

  2. Genetic and epigenetic screening for gene alterations of the chromatin-remodelling factor, SMARCA4/BRG1, in lung tumors

    Genes Chromosomes and Cancer, Vol. 41, Núm. 2, pp. 170-177

  3. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene

    Oncogene, Vol. 23, Núm. 22, pp. 4037-4040

2003

  1. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations

    Cancer Epidemiology Biomarkers and Prevention, Vol. 12, Núm. 8, pp. 699-704